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Dominant, Hierarchical Induction
of Peripheral Tolerance during Foreign
Antigen-Driven B Cell Development
peripheral B cell tolerance as irreversible, resulting in
a subpopulation of B cells which, although physically
present, is functionally incompetent (Cooke et al., 1994;
Nguyen et al., 1997). However, recent studies have dem-
onstrated that provision of strong BCR signals and either
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genuine or surrogate T cell help can result in the activa-
tion of self-antigen-regulated B cells (Noorchashm et
al., 1999; Sater et al., 1998; Seo et al., 2002). Thus, self-Summary
tolerant B cells with BCRs that are “dual reactive” for
both self and foreign antigen could theoretically be re-We created mice expressing transgene-encoded
cruited to participate in a foreign antigen-driven immuneBCRs with “dual reactivity” for the hapten Ars and
response. This may occur when a response is driven bynuclear autoantigens. Expression of transgene-encoded
a foreign antigen that contains a B cell epitope to whichBCRs was not evident in the memory compartment
an autoreactive B cell is crossreactive. Indeed, the etio-despite observation of transgene-expressing B cells
logies of certain autoimmune diseases have been sug-in germinal centers following Ars immunization. In
gested to be a consequence of foreign antigen mimick-contrast, dual reactive mAbs were readily obtained
ing self-antigen (Oldstone, 1998). In this regard, manyfrom mice with enforced expression of Bcl-2 following
pathogens express epitopes that are immunologicallysecondary Ars immunization. However, while these
crossreactive with self-epitopes (reviewed in KarlsenmAbs were hypermutated and displayed increased af-
and Dyrberg, 1998). Also, a foreign antigen that is boundfinity for Ars, all had reduced avidity for DNA and intra-
to a self-antigen could stimulate peripheral autoreactivecellular autoantigens. Thus, Bcl-2 alters dominant-
B cells via recruitment of T cell help (Krishnan and Mar-negative selection of dual reactive B cells during the
ion, 1993; Moens et al., 1995; Parker and Eynon, 1991).Ars response, but this is restricted to those with low-
For these reasons, it has been argued that peripheralered autoreactivity, demonstrating a hierarchy of pe-
tolerance mechanisms must exist that are operative dur-ripheral tolerance during memory B cell development.
ing the B cell response (Hande et al., 1998; Linton et al.,
1991). However, whether self-antigen-regulated B cellsIntroduction
are prevented from contributing to the memory compart-
ment due to such tolerance mechanisms has not beenDeveloping B cells with antigen receptors (BCRs) that
adequately examined.bind self-antigens in the bone marrow may be deleted
We have shown that B cells with low-affinity, multire-by apoptosis (Chen et al., 1995; Nemazee and Burki,
active antigen receptors can participate in a foreign anti-1989) or undergo receptor editing (Gay et al., 1993; Tiegs
gen-driven immune response (Hande et al., 1998). Theet al., 1993). However, not all autoreactive B cells are
antibodies that dominate the late primary and anamnes-eliminated by these processes, as the primary peripheral
tic responses to the hapten p-azophenylarsonate (Ars)B cell compartment in nonautoimmune mice is charac-
in A strain mice are encoded by a single combinationterized by the expression of multireactive BCRs that
of V gene segments (termed canonical). Prior to somaticbind a variety of self-antigens (Limpanasithikul et al.,
mutation, they differ only at VL-JL and VH-D-JH junctions1995; Rousseau et al., 1989) and of autoreactive B cells
and exhibit weak binding to nuclear and cytoplasmicwith specificities for autoantigens not expressed in the
structures, as well as DNA (Manser et al., 1987; Napars-
bone marrow (Litzenburger et al., 1998; Murakami et al.,
tek et al., 1986). In contrast, hypermutated canonical
1992). In addition, considering the rate of variable (V)
antibodies expressed by memory B cells have increased
region mutation in the germinal center (GC), B cells ex- affinity for Ars but do not detectably bind self-antigens
pressing autoreactive antibodies must frequently arise (Naparstek et al., 1986). These data suggest that both
during foreign antigen-driven immune responses (Cas- positive and negative selection, acting in conjunction
son and Manser, 1995; Diamond et al., 1992). with V region hypermutation, purge the responding B
Autoreactive peripheral B cells are often argued to be cell population of autoreactivity. Consequently, we de-
ignorant of self-antigens due to low concentrations or veloped the specificity maturation hypothesis which
sequestration of their cognate autoantigens (Goodnow, contends that the driving force behind the maturation of
1992; Nossal, 1993). However, it has become evident the B cell response is specificity for the foreign antigen
that tolerance to peripheral autoantigens can be actively rather than affinity alone (Casson and Manser, 1995;
imposed, resulting in ultimate cell death (Monroe, 1998; Hande et al., 1998). However, due to the low affinity of
Rathmell et al., 1995), anergy (Erikson et al., 1991; Good- unmutated, canonical V regions for self-antigens, we
now et al., 1988), or follicular exclusion (Cyster et al., considered that B cells expressing such V regions were
1994; Mandik-Nayak et al., 1997). The developmental functionally ignorant of these antigens prior to entering
potential of autoreactive peripheral B cells subjected to the memory B cell pathway.
such active regulation remains controversial. Some view Therefore, we sought to create a model system in
which B cells expressing canonical V regions with strong
self-reactivity were members of the peripheral compart-1Correspondence: manser@mail.jci.tju.edu
2 These authors contributed equally to this work. ment. To this end, we exploited our previous finding that
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Figure 1. Autoreactivities Conferred to Canonical V Regions by the R55 Mutation
(A) The R55 mutation confers ssDNA reactivity to canonical V regions that is comparable to that displayed by PL9-6, while the dsDNA reactivity
is 4-fold lower than PL9-6. The R55 mutation also confers chromatin reactivity, which is completely lacking in the unmutated canonical
mAb, 36-65/223.
(B) Injecting transfectoma cells secreting the R55/223 mAb into pristane-primed SCID mice results in immune complex deposition in kidney
glomeruli, but injection of 36-65/223 transfectoma cells does not. Original magnification of images was 100.
(C) The R55 mutation confers nuclear, perinuclear, and cytoplasmic reactivities to canonical V regions as determined by ANA assays. Note
the strong binding to mitotic figures. A similar analysis using the unmutated canonical mAb 36-65/223 gave negative results even at 25 g/
ml of purified mAb. Original magnification of all images was 250.
an arginine (R) mutation at position 55 in VHCDR2 of mutation. The reactivity of this mAb was examined by
ELISAs, as well as ANA assays (Figures 1A and 1C) andcanonical V regions substantially increases binding to
Ars-tyrosine fluorescence quenching (see below). TheDNA without affecting affinity for Ars (Hande and
R55 mutation confers a substantial increase in reactivityManser, 1998) and generated transgenic mouse lines
for DNA. The ssDNA reactivity was comparable to thatusing a canonical VH region gene containing the R55
of PL9-6, an anti-chromatin antibody obtained from amutation. This allowed us to address whether truly dual
diseased MRL mouse (Losman et al., 1993) while dsDNAreactive B cells could be recruited into the immune re-
binding was approximately 4-fold lower than PL9-6 (Fig-sponse and, if so, whether they could contribute to the
ure 1A). More strikingly, the R55 mutation conferredmemory B cell compartment via specificity maturation.
chromatin binding and other intracellular autoantigen
reactivities, which are not exhibited by unmutated IgG
Results canonical antibodies (Figure 1). The R55/223 mAb
stained nuclear, perinuclear, and cytoplasmic structures
The R55 Mutation Confers Chromatin, ANA, (Figure 1C). Furthermore, injecting the R55/223 transfec-
and Increased DNA Reactivity toma into SCID mice resulted in immune complex depo-
An Ig expression vector encoding a canonical H chain sition in kidney glomeruli. There was no evidence of
with the R55 mutation (R55/223) was transfected into the such deposition in SCID mice injected with the 36-65/
hybridoma line 36-65L (Sharon et al., 1984) expressing a 233 (unmutated canonical) transfectoma (Figure 1B). Fi-
canonical light (L) chain but no heavy (H) chain, resulting nally, the R55 mutation did not significantly alter affinity
for Ars (see below).in the production of a canonical mAb with only this
Memory B Cell Tolerance
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Figure 2. Somatic and Germline Modification of the Endogenous IgH Locus by R55VH Transgenes
(A) The VR55 and VER55 transgene structure and schematic representation of the nonreciprocal recombination event leading to the generation
of transgene-hybrid H chain loci is shown. This recombination occurs in B cells as the result of homologous pairing between a region 3 of
the coding VDJ of one transgene copy in the transgenic array and the analogous region in the IgH locus. The homologous pairing and
recombination site is indicated with solid crossed lines, and the nonhomologous recombination site is indicated with dotted crossed lines.
The result of this recombination event is the integration of the transgenic VH region into the endogenous IgH locus.
(B) The structure of the HKIR R55 targeting vector and the recombination events leading to the generation of the R55VH germline knockin IgH
locus are illustrated. The introduction of novel StuI sites into the IgH locus via the incorporation of R55 VH DNA allows a Southern blot assay
for this locus to be performed using the J14C-S probe (location shown with a black bar).
Generation and Characteristics of Transgenic Mice ation of the B cell repertoire (Giusti et al., 1992). Trans-
gene hybrid H chain loci can undergo somatic hypermu-To create mice expressing canonical BCRs with the R55
mutation, two approaches were taken. Lines of trans- tation and isotype class switching (Giusti et al., 1992).
The above transgenic mice allowed analysis of thegenic mice, termed VR55 and VER55, were generated
using a canonical R55VH region gene. The Ig transgenes behavior of canonical R55 VH-expressing clonotypes in
a nearly normal physiological context, where B cellsused did not contain constant region gene(s) and there-
fore could not encode complete H chains. Our previous expressing canonical BCRs encoded by endogenous
genes also participate in the anti-Ars response (Giustistudies have shown that VH transgenes of this type inte-
grate into the germline IgH locus via a somatic interchro- et al., 1992). However, the extremely low precursor fre-
quency of transgene-expressing canonical clonotypesmosomal one-sided homologous recombination event,
illustrated in Figure 2A (Giusti et al., 1992). The formation in such mice precludes quantitative analysis of their
location and phenotype prior to and after primary immu-of the resulting hybrid H chain loci takes place at a
frequency comparable to individual endogenous VH nization (Vora et al., 1999). Therefore, more conventional
lines of canonical R55VH IgH locus knockin transgenicgene rearrangements, resulting in only a subtle alter-
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Table 1. Summary of B Cell Fusions from VR55 and VER55 Splenocytes
# Fusions # Fusions
# E4 # Transgene # E4 # Transgene
Founders Primarya Secondaryb Tertiaryb Hybridomas Hybridomasd Hyperimmunizationc Hybridomas Hybridomas
VR55-50 3 3 – 11 0 9 9 0
VR55-46 5 – – 2 0 5 8 0
VR55-32 5 6 5 13 0 4 5 0
VR55-54 4 – – 0 0 3 13 0
VER55-89 –e – – – – 11 27 1
VER55-102 – 4 – 30 0 1 3 0
VER55-148 – – – – – 8 38 0
VER55-142 – 2 – 2 0 – – –
Totals 17 15 5 58 0 41 105 1
BVER55 – 4 – 34 13 – – –
a Primary fusions were performed at days 4, 7, 10, 12, and 15 postimmunization with 100 g of Ars-KLH emulsified in CFA.
b For secondary immune responses mice were boosted with 50 g of Ars-KLH in PBS at least 1 month after priming, while for tertiary immune
response mice were boosted with 50 g of Ars-KLH in PBS at least 1 month after priming and then once again 1 month later. All B cell fusions
were performed 3 days following the final boost.
cMice were primed with 100 g of Ars-KLH emulsified in CFA, boosted 1 week later with 50 g of Ars-KLH in PBS, and then boosted with 50
g of Ars-KLH in PBS three more times every other day. Fusions were performed 3 days following the final boost.
d All of the B cell hybridomas generated were screened for reactivity with the anti-idiotypic antibodies E4 and 107; transgene expression status
was confirmed by RT-PCR sequence analysis.
e Dashes (–) indicate no fusions performed.
mice, termed HKIR mice, were generated via homolo- tertiary immune responses, but the levels were substan-
tially lower than those previously observed (Giusti etgous recombination in ES cells. Figure 2B illustrates
the approach taken and the structure of the resulting al., 1992) in other animals transgenic for the unmutated
canonical VH region.knockin germline IgH locus (see Experimental Proce-
dures for details). The extremely infrequent isolation of hybridomas ex-
pressing canonical R55VH antibodies from Ars-immu-
nized VR55 and VER55 mice could have resulted fromTransgenic R55VH Regions Are Rarely Expressed
by Canonical Hybridomas Derived from Ars- the inability of their B cell precursors to escape a toler-
ance checkpoint prior to the Ars response. To addressImmunized VER55 and VR55 Mice
Splenic B cell hybridomas were generated from VR55 this issue, we analyzed primary development of canoni-
cal R55VH B cells in the HKIR mice. Development in theand VER55 mice at various times after primary, second-
ary, tertiary, and hyperimmunization with Ars-KLH. Their bone marrow appeared normal as compared to lit-
termate controls (data not shown). As shown in Figureexpression of canonical mAbs was evaluated using the
monoclonal anti-idiotypic Ab E4, which recognizes most 3A, most if not all HKIR E4 splenic B cells do not
express an endogenouschain. Moreover, a substantialcanonical VH regions (Hiernaux et al., 1983; Manser and
Gefter, 1986), and the monoclonal anti-idiotypic Ab 107, fraction of HKIR spleen cells stained with the E4 mAb
(data not shown), demonstrating that B cells expressinghighly specific for the transgenic VH region (Giusti et al.,
1992; Weissman et al., 1985). Based on the yield of E4 canonical R55VH BCRs can exit the bone marrow and
populate the periphery. In addition, such B cells exhibithybridomas, there was a normal frequency of canonical
B cell participation in the anti-Ars response (Table 1). what appears to be a follicular phenotype, as defined
by CD21, CD23, and CD24 expression (Figures 3B andHowever, only one of the 163 canonical splenic hybrido-
mas generated from a total of 78 VR55 and VER55 mice 3C). These results were corroborated via immunohisto-
chemical analysis, revealing numerous E4 cellsexpressed the transgenic VH region (Table 1). The mAb
expressed by this hybridoma bound Ars with avidity throughout follicular areas (data not shown). Nonethe-
less, flow cytometric analyses showed that both sIgMcomparable to 36-65, the prototypical canonical mAb
(Marshak-Rothstein et al., 1980), but did not bind ssDNA and sIgD levels were substantially reduced on E4 HKIR
splenic B cells relative to the majority of B cells in theseor dsDNA as determined by ELISA. Sequence analysis of
the transgenic VHR55 gene expressed by this hybridoma mice (Figure 3D).
Next, we performed immunohistochemical analysis ofshowed that the R55 codon was unaltered. However,
there were secondary mutations in the VH region that the spleens of VER55 mice at various times after primary
immunization with Ars-KLH. As expected from our previ-must account for the attenuation of DNA binding dis-
played by this mAb (data not shown). ous studies of A/J mice (Vora et al., 1999), E4 cells
were infrequently detected in the spleens of these mice,Consistent with the extremely low yield of hybridomas
from VR55 and VER55 mice that expressed the trans- and then only in GCs. As illustrated in Figure 4A, some of
these GCs contained multiple E4 cells that also stainedgenic R55VH, 107 serum antibody was low or absent in
VR55 mice following Ars immunization (data not shown). with the 107 mAb, indicating the presence of canonical
R55VH transgene-expressing B cells. To increase theTwo of five VR55 mice analyzed displayed a slight in-
crease in 107 serum antibody during secondary and frequency of canonical R55VH-expressing B cells partici-
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Figure 3. Most Canonical R55VH B Cells Dis-
play a Follicular Phenotype but Express Re-
duced Surface Levels of BCR
HKIR mice were crossed to C57BL/6 mice,
and offspring containing (HKIR) and lacking
(littermates) the targeted allele were identi-
fied. Splenocytes from both were evaluated
for expression of surface markers via flow
cytometry.
(A) B220 or E4 cells were assayed for ex-
pression of the IgM allotype encoded by the
knockin allele (IgMa) or the endogenous
C57BL/6 IgH locus (IgMb).
(B) B220 or E4 cells were evaluated for ex-
pression of CD21/35 and CD23 to allow dis-
tinction of marginal zone (MZ) versus follicu-
lar B cells. Equivalent gates were set around
the MZ (upper left) and follicular (lower right)
B cell subpopulations. Note that E4 HKIR B
cells are not enriched in the MZ subpopula-
tion (CD21high,CD23low).
(C) B220 and E4 cells were evaluated for
levels of expression of CD24 (HSA) and CD21/
35 to allow quantitation of T1 and T2 transi-
tional B cell subcompartments. Equivalent
gates were set around these (lower right, T1;
upper right, T2) and the follicular B cell sub-
population (left).
(D) B220, E4, or total cells in the lympho-
cyte gate were analyzed for surface levels of
IgM and IgD. Note that while the bulk lympho-
cyte population in HKIR mice displays a fairly
normal IgM versus IgD profile as compared to
littermates, the majority of E4 cells in these
mice display substantially reduced levels of
both surface IgM and IgD.
pating in the response, we transferred HKIR splenocytes region, VER55 mice were crossed to A.Bcl-2 mice
(Hande et al., 1998) resulting in a double transgenicto syngeneic recipients and immunized them with Ars-
KLH. Twelve days later, vigorous GC and AFC responses line called BVER55. Transgene-expressing splenic B cell
hybridomas were readily obtained from BVER55 mice.were apparent in the spleens of the recipient mice, and
E4 cells could be observed in many GCs (Figure 4B). Nearly one-third of the secondary hybridomas from Ars-
KLH-immunized BVER55 mice expressed the transgenic
R55VH region (Table 1). Furthermore, approximately 50%Enforced Expression of Bcl-2 Results in a Dramatic
Increase in Splenic Hybridomas Expressing of the hybridomas generated from three out of four
BVER55 mice expressed the transgene encoded R55VHthe Transgenic R55VH Region
Enforced expression of Bcl-2 in the B cell compartment region.
of A strain mice from a transgene results in a large
decrease in the level of apoptosis in the GC and in The R55 Mutation in Canonical VH Regions Does Not
Affect Somatic Hypermutation or Affinity Maturationthe ability of B cells expressing canonical BCRs with
increased affinity for both Ars and DNA to enter the to Ars in Bcl-2 Transgenic Mice
We previously concluded that enforced expression ofArs-induced memory B cell compartment (Hande et al.,
1998). To test whether Bcl-2 could alter the negative Bcl-2 did not alter somatic hypermutation or affinity mat-
uration of endogenous canonical V regions (Notidis etselection of B cells expressing the transgenic R55VH
Immunity
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Figure 4. Canonical R55VH B Cells Are Evident in GCs during a Primary Ars Response
(A) Parallel spleen sections from a VER55 mouse at day 14 postimmunization with Ars-KLH were stained with 107, which recognizes the
transgenic VHR55 region, and either GK1.5, which delineates CD4 T cells, or PNA, to elaborate GCs. Another parallel section was also stained
with E4 to delineate canonical B cells, and also with PNA. An analysis of 11 VER55 mice sacrificed at various times after Ars-KLH immunization
revealed that out of 19 E4 GCs, 5 were also 107. Original magnification of images was 100.
(B) Splenocytes from HKIR mice were transferred to syngeneic recipients, and the recipients were immunized with Ars-KLH and sacrificed
12 days thereafter. Spleens were taken, processed for histology, and stained as described in the Experimental Procedures. Several examples
of GCs containing numerous E4 cells are illustrated. The results are representative of those obtained from four chimeric mice. Original
magnification of images was either 100 or 250.
(C) Littermate spleen sections were stained with either 107 or E4 and GK1.5 under the same conditions as used above to evaluate background
levels of staining with these mAbs. For unknown reasons, central arterioles stain blue with developing reagent. Original magnification was
100.
al., 2001). To evaluate whether the R55 mutation affected genic R55VH region using Ars-N-acetyl-L-tyrosine (Table
2). The average KA of these mAbs was 1.6  107 M1,these processes, we conducted sequence analysis of
the VH and V genes expressed by the canonical hybrido- substantially higher than the KA of unmutated canonical
mAbs such as 36-65, as well as R55/223 (Table 2). Inmas from BVER55 mice. The transgene encoded R55VH
regions had overall levels, and frequencies of mutation total, all of the transgene-encoded mAbs had increased
affinity for Ars, while 8 out of 13 had at least 10-foldclustered to mutational hot spots (Rogozin and Kolcha-
nov, 1992; Shapiro et al., 1999) comparable to those in increased affinity. This increase in KA is characteristic
of affinity-matured, hypermutated canonical antibodiesendogenously encoded canonical VH regions obtained
from the same mice. All of the V genes coexpressed expressed during an Ars immune response in nontrans-
genic A strain mice (Manser, 1991).with the transgene-encoded VH region were canonical
and displayed levels of somatic mutation similar to the
canonical V genes coexpressed with VH regions en- Canonical mAbs from BVER55 Mice Display
Reduced Binding to Autoantigenscoded by endogenous IgH loci. Nearly half of the trans-
gene-encoded VH regions had the Thr58→Ile mutation, To investigate whether the autoantigen binding capabili-
ties conferred by the R55 mutation were attenuated inpreviously shown to increase the Ars affinity of canonical
V regions (Casson and Manser, 1995; Sharon et al., 1989) the canonical BCRs expressed by B cells that had under-
gone Ars-driven somatic mutation and selection in(data not shown).
Affinity maturation was confirmed by fluorescence BVER55 mice, R55VH transgene-encoded mAbs ob-
tained from this line were tested for ssDNA, dsDNA, andquenching analysis of BVER mAbs containing the trans-
Memory B Cell Tolerance
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mAb gave rise to mainly perinuclear and weak nuclearTable 2. Ars Affinities of Purified mAbs Containing the Transgenic
staining, which excluded some nuclear structures, andVH Region
this staining was less intense than that conferred by
mAb Affinity (KA  M1)a the R55 mutation alone, even at high concentrations of
Unmutated Canonical Control 36-65 4.7  105 antibody.
R55 Mutated Canonical Control R55/223 4.4  105
mAbs from BVER55 Secondary Fusions
11-C4 1.6  107
Discussion11-C7 6.1  105, 4.7  105
11-A4 1.1  107, 3.0  107
22-5E12-B7 6.0  106 Several studies have suggested that self-antigen-regu-
22-1E12-F6 1.5  106, 9.0  105 lated B cells may be capable of participating in foreign
22-4B10-C8 1.3  108 antigen-driven immune responses (Cooke et al., 1994;
22-3B9-E6 1.3  108 Noorchashm et al., 1999; Sater et al., 1998; Seo et al.,
23-1G5-F9 8.7  105, 7.8  105
2002), raising the possibility that autoreactive memory B24-4A11-D6 6.0  106, 7.0  106
cells could develop during such responses. Our data show24-3C12-D3 8.7  105, 6.1  105
24-1H9-D6 2.4  106, 3.3  106 that although canonical R55VH transgene-expressing B
24-1E7-F1 1.3  108 cells colonize follicles and can participate in the foreign
24-1F9-F3 8.7  105, 1.6  106 antigen-induced GC response, they appear incapable
a Multiple KA values were each obtained from an independent exper- of entering the memory compartment. Thus, the data
iment. suggest that negative selection by self-antigen is domi-
nant over positive selection for increased affinity for
foreign antigen during the BCR mutation-selection pro-
cess. Furthermore, enforced expression of Bcl-2 per-chromatin binding (Figure 5). Most of the transgene-
turbed the negative selection of B cell clones expressingencoded mAbs retained their ability to bind ssDNA and
the transgenic R55VH region such that their BCRs weredsDNA. However, all displayed reduced binding to these
readily detected in the Ars-induced memory compart-autoantigens as compared to the R55/233 mAb (Figure
ment, but these BCRs had altered autoreactivities. All5). Moreover, all of the mAbs exhibited very weak or
of the transgene-encoded canonical mAbs isolated fromundetectable binding to chromatin (Figure 5). ANA reac-
BVER55 mice bound less well to nucleic acid autoanti-tivities of the mAbs containing the transgenic R55VH
gens than the unmutated canonical R55 V region. Thus,were compared to PL9-6 and 36-65, which are ANA
the ability of Bcl-2 to modify the negative selection ofpositive and negative under the conditions used, re-
B cells with certain autoreactivities and not others sug-spectively (data not shown). Only 1 out of the 13 mAbs
gave a detectable signal in these assays. However, this gests a hierarchy of peripheral negative selection by
Figure 5. Relative Binding of BVER55 Secondary mAbs to Chromatin, ssDNA, and dsDNA
Purified transgene-encoded mAbs derived from secondary anti-Ars responses of four BVER55 mice were evaluated for relative binding to
these ligands by ELISA. These binding activities were compared to those of PL9-6 (filled triangles, dashed line), R55/223 (filled diamonds,
solid line), and 36-65/223 (filled squares, dashed line).
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autoantigen(s) during the mutation-selection pathway these two factors could result in chromatin being a
stronger tolerogen. In general, ubiquitous intracellularleading to memory B cell development.
In accordance with previous studies (Goodnow et al., autoantigens such as chromatin may be readily available
in the GC, perhaps on the surface of apoptotic cells1988; Mandik-Nayak et al., 1997), our finding in HKIR
mice that surface IgM and IgD levels on canonical R55VH (Rosen et al., 1995), but other self-antigens may be less
accessible to hypermutating B cells. Studies by Reedpreimmune B cells are reduced indicates that such cells
are subjected to self-antigen-mediated regulation, i.e., et al. (2000) on transgenic mice expressing influenza
hemagglutinin (HA) as a neo-self-antigen suggested thatthey are not ignorant of self-antigens. In agreement with
this idea, Ars-KLH immunization induced canonical anti-HA B cells were not subjected to a peripheral toler-
ance checkpoint during memory B cell genesis. TheR55VH-expressing B cells to enter GCs, but none of the
AFCs observed during this response were E4. While above arguments would predict that in these mice HA
is not expressed at significant levels in GCs.further studies will be required to completely elucidate
the phenotypic status and functional potential of preim- Since canonical R55VH transgene-expressing-B cells
were detected in GCs but appeared to be grossly under-mune canonical R55VH B cells, these observations sup-
port the conclusion that self-antigen-regulated B cells represented in the memory compartment in the absence
of enforced Bcl-2 expression, it is possible that the self-can enter the memory B cell specificity maturation path-
way when stimulated by foreign antigen. reactivity conferred by R55 could not be completely
revised via V gene hypermutation. Indeed, all of theA previous study of B cells in a conventional Ig trans-
genic line of mice expressing an unmutated, canonical R55VH genes expressed by the BVER55 hybridomas had
an intact R55 codon, demonstrating that the alterationsVH gene and a heavily mutated, canonical light chain
gene revealed downregulation of sIgM but elevated lev- in the autospecificities of the encoded mAbs resulted
from second site mutations. Therefore, the R55 codonels of sIgD and that these cells were incapable of re-
sponding to Ars immunization in vivo or BCR engage- may be a hypermutation cold spot (Radmacher et al.,
1998). Consequently, the inability of second site muta-ment in vitro (Benschop et al., 2001). Like canonical R55
V regions, the particular VH:VL combination expressed tions to ablate the autoreactivity conferred by the R55
mutation may have resulted in the deletion of nearly allin these mice binds Ars with low affinity, but it differs
in binding DNA poorly. The reasons for the distinct be- transgene-expressing B cells within the GC in mice not
expressing the Bcl-2 transgene. This may account forhaviors of B cells expressing these two forms of canoni-
cal V regions will require further analysis. However, it is our observation that GCs containing canonical R55VH-
expressing B cells were rare in Ars-KLH-immunizedlikely that differences in the specificities and levels of
expression of their BCRs are major contributing factors VR55 and VER55 mice. Such GCs could be easily ob-
served in immunized HKIR chimeric mice, but this proba-(Heltemes and Manser, 2002).
One explanation for the dominance of negative selec- bly resulted from the elevation of the frequency of ca-
nonical R55VH-expressing precursors. Accordingly, thetion by autoantigen over positive selection by foreign
antigen during specificity maturation may be provided one canonical R55VH transgene-encoded mAb identified
in a total of 163 canonical hybridomas isolated fromby the order of these events. Positive selection of B
cells expressing high-affinity BCRs is argued to be medi- VR55 and VER55 mice lacked DNA reactivity and was
a somatically mutated IgG. Collectively, these data sup-ated via the interaction of the BCR with immune com-
plexes (IC) deposited on follicular dendritic cells (FDCs), port the idea that memory B cell precursors are suscepti-
ble to a stringent peripheral tolerance mechanism(s) op-while negative selection is suggested to occur through
interaction with CD4 T cells (MacLennan, 1994). Given erative in the GC (Han et al., 1995; Linton et al., 1991;
Pulendran et al., 1995; Shokat and Goodnow, 1995).these ideas, B cells given a survival signal following
interaction with IC on FDCs may present the antigen Since autoantibodies with high affinity for native nu-
clear antigens such as chromatin are characteristic ofacquired from these IC to CD4 T cells (MacLennan,
1994). Self-reactive B cells that attempt to present au- many systemic autoimmune diseases, the need for neg-
ative regulation of such specificities seems obvious. Intoantigen or are precluded from presenting foreign anti-
gen to tolerant CD4 T cells are negatively selected contrast, whether B cells with reactivity for naked DNA
pose a pathologic threat has been less clear. Nonethe-via altered signaling in the absence of costimulation
(Goodnow et al., 1995) or by Fas-mediated apoptosis less, although DNA reactive B cells have been demon-
strated to be common residents of the periphery of nor-(Rathmell et al., 1995). Thus, positive selection via IC on
FDCs may occur prior to negative selection via T cell mal individuals (Limpanasithikul et al., 1995; Rousseau
et al., 1989) and to arise as a consequence of somaticinteraction, and accordingly, the dominance of negative
selection over positive selection may naturally follow. hypermutation (Casson and Manser, 1995; Diamond et
al., 1992), most data are consistent with those presentedThe reduced but not ablated autoreactivities of canon-
ical R55VH-encoded mAbs isolated from BVER mice may here in supporting the idea that such cells do not enter
the memory compartment under normal conditions (Bor-be attributed to the difference in affinities of the trans-
genic R55VH region for different forms of nucleic acid retzen et al., 1994; Hande et al., 1998; Naparstek et al.,
1986). The physiological significance of the regulationautoantigens. If developing memory B cells expressing
the transgenic R55VH region have a higher affinity for of B cell DNA reactivity has been suggested by recent
studies of DNase I-deficient mice. These mice developchromatin than free DNA, binding to chromatin may re-
sult both in more extensive crosslinking of the BCR than high titers of pathogenic autoantibodies, apparently due
to altered clearance of extracellular DNA (Napirei et al.,when DNA is bound and in the transmission of a death
signal to the cell. In addition, free DNA may be scarce 2000; Walport, 2000).
B cell tolerance begins in the bone marrow, whereas compared to chromatin in vivo. The combination of
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recipient) via tail vein injection. Twelve hours later the chimeric miceimmature B cells with BCRs capable of binding self-
were immunized with 100 g of Ars-KLH in alum IP. At variousantigen are eliminated by clonal deletion (Chen et al.,
times thereafter, the mice were killed, and spleens were taken and1995; Nemazee and Burki, 1989) or undergo receptor
processed for histology.
revision (Gay et al., 1993; Tiegs et al., 1993). Subse-
quently, autoreactive B cells that enter the periphery are
Flow Cytometry
either clonally ignorant (Goodnow, 1992; Nossal, 1993), Single-cell suspensions were prepared from lymphoid organs of
rendered anergic (Erikson et al., 1991; Goodnow et al., 8- to 10-week old, naive HKIR mice and age-matched transgene-
1988), or deleted by self-antigen (Monroe, 1998; Rath- negative littermates. Cells were stained with different combinations
of the following antibodies: 	-IgM-FITC (Jackson ImmunoResearch;mell et al., 1995). If autoreactive memory B cells do
West Grove, PA), 	-IgD-PE (clone 11-26; Southern Biotechnologydevelop, they may be subjected to tolerance mecha-
Associates), 	-IgMa-FITC (clone DS-1), 	-IgMb-PE (clone AF6-78),nisms that preclude their differentiation to AFC (Hande
	-CD21/35-FITC (clone 7G6), 	-CD23-PE (clone B3B4), 	-CD24-PE
et al., 1998; Walker and Weigle, 1985). The data pre- (HSA, clone M1/69), 	-CD45R-biotin, -FITC, and -PE (B220, clone
sented here demonstrate that B cells that are strongly RA3-6B2) (biotin; eBioscience, San Diego, CA), or 	-idiotypic biotin-
reactive with intracellular autoantigens and are recruited ylated mAb E4. All antibodies were obtained from BD Biosciences,
Pharmingen (San Diego, CA) unless otherwise indicated. Anti-idioty-to participate in a TD immune response are subjected to
pic antibodies were purified and biotinylated using standard meth-peripheral tolerance mechanisms during the mutation-
ods. CyChrome (BD Biosciences, Pharmingen, San Diego, CA) wasselection memory B cell pathway. Enforced expression
used as a second step reagent. Cells were fixed in 1% paraformalde-
of Bcl-2 alters this process and permits B cell clones hyde, assayed on a Coulter Epics Elite, and data analyzed using
with certain autoreactivities to enter the memory com- FLOWJO software (Treestar; San Carlos, CA).
partment. Collectively, these data support the existence
of hierarchical peripheral tolerance mechanisms opera- Hybridomas
tive during multiple stages of both primary and second- VR55, VER55, and BVER55 mice at least 8 weeks of age were primed
IP with 100 g of Ars-KLH emulsified in complete Freund’s adjuvantary B cell development.
(CFA). Some mice were then boosted IP with 50 g Ars-KLH in
PBS at least 1 month after primary immunization for secondary
Experimental Procedures responses. For tertiary responses, mice were boosted IP with 50
g Ars-KLH in PBS at least 1 month after primary immunization and
Transgenic, Knockin, and Chimeric Mice once again at least 1 month later. Mice were sacrificed at various
The generation of the pVHXbaRI/R55 and pVHXbaI3Enh/R55 vectors time points during primary responses (days 4, 7, 10, 12, and 15) and
for the construction of the VR55 and VER55 transgenic mice, respec- 3 days after the final boost for secondary and tertiary responses.
tively, was similar to that described (Giusti et al., 1992). Both contain For hyperimmunizations, mice were primed with 100 g Ars-KLH in
a H chain VHDJH exon from the 36-65 hybridoma (Marshak-Rothstein CFA, boosted a week later with 50 g Ars-KLH in PBS, and then
et al., 1980) with an AAT (Asn) → CGA (Arg) mutation at codon 55, boosted three more times with this amount of antigen, once every
the rare V-D and D-J junctions of 36-65, 5 flanking VH leader and other day. Spleen cells were used to generate hybridomas as de-
promoter elements, and plasmid flanking DNA. The rare junctions scribed (Manser, 1989) using the Sp2/0 fusion partner. Hybridoma
confer reactivity with the anti-idiotypic antibody 107 (Giusti et al., supernatants were screened for the presence of canonical antibod-
1992; Weissman et al., 1985) allowing for distinction between endog- ies via an anti-idiotypic (E4) ELISA (Casson and Manser, 1995; Hande
enous canonical VH regions and transgene-encoded VH regions. Both et al., 1998). E4 hybridomas were subcloned by limiting dilution.
constructs lack any switch or constant region DNA. pVHXbaI3Enh/
R55 also contains the 3 H chain enhancer (hs 1,2) and 500 bp of
Purification of mAbs, mAb Binding Assays,SV40 intronic sequence. The resulting lines of mice were back-
and Determination of mAb Affinitycrossed to A strain mice for at least five generations. To obtain
mAbs were purified from hybridoma supernatants using protein Gthe BVER55 mouse line, the VER5589 line was crossed to A.Bcl-2
chromatography (Pharmacia Biotech, Uppsala, Sweden) accordingtransgenic mice (Hande et al., 1998; McDonnell et al., 1989).
to the manufacturer’s suggestions. E4 and DNA reactivities wereThe pKI-36-65Arg vector used to create the HKIR line of VH knockin measured by solid-phase ELISAs as described before (Casson andmice was generated using the pKO Scrambler series from Stra-
Manser, 1995; Hande et al., 1998). Chromatin reactivity was mea-tagene (La Jolla, CA). Restriction fragments containing the Diptheria
sured by ELISA as described elsewhere (Fowler and Cheng, 1983).toxin gene (pKO SelectDT) and the neomycin gene with flanking
Bound antibodies were elaborated with a biotinylated rat anti-mouseloxP sites (Osdupl; provided by Dr. Oliver Smithies) were cloned
mAb followed by streptavidin alkaline phosphatase (AP) (Southerninto the pKO Scrambler V908 vector. The Balb/c DQ52 gene and
Biotechnology Associates, Inc., Birmingham, AL) and PNPP (Sigmaflanking sequence was excised as a 2.3 kb fragment from a plasmid
Chemical Diagnostics, St. Louis, MO). The affinities of purified anti-vector (Dirkes et al., 1994), and a 1 kb region containing the 129/
bodies were determined by fluorescence quenching using Ars-SvJ IgH intronic enhancer and 5 flanking sequence (3 recombina-
N-acetyl-L-tyrosine as previously described (Hande et al., 1998;tion site) was PCR amplified, and both were cloned into the vector.
Rothstein and Gefter, 1983) and a Perkin-Elmer (model LS-50) spec-Finally, the 36-65 VDJ fragment was PCR amplified using primers
trophotofluorimeter.that introduced the position 55 AAT → CGA (R) change as was
previously described (Casson and Manser, 1995) and was cloned
into the vector. NotI linearized vector was transfected into a 129/ Immunohistochemistry
Spleens were removed, flash frozen, sectioned, and fixed as pre-SvJ ES cell line obtained from Incyte Genomics (St. Louis, MO).
Subclones containing appropriately targeted alleles were identified viously described (Jacob et al., 1991). Five to six micrometer frozen
sections were thawed, rehydrated, and stained as before (Handeby Southern blot assaying for the presence of a 2.1 kb StuI fragment
from the targeted allele as compared to a 4.7 kb fragment derived et al., 1998; Jacob et al., 1991). To identify canonical antibody-
expressing cells, sections were incubated with either biotinylatedfrom the wild-type allele using the J14C-S probe (see Figure 2).
Genomic DNA was prepared from ES cells as described by Stra- E4 or 107, washed in TBS/BSA, and then incubated with Streptavi-
din-AP (Southern Biotechnology Associates, Inc. Birmingham, AL).tagene (La Jolla, CA). ES cell subclones were microinjected into
C57BL/6 blastocysts, and the resulting chimeras were crossed to GCs and CD4 T cells were identified with PNA (E-Y Laboratories,
San Mateo, CA) and the mAb GK1.5 coupled to horseradish peroxi-C57BL/6 mice. Agouti offspring were screened by Southern blot
hybridization of StuI digested tail DNA with the J14 C-S probe. dase (HRP), respectively. Bound AP and HRP activities were visual-
ized using Napthol AS-MX/Fast Blue BB Base and 3-aminoethylcar-For some experiments, RBC-depleted HKIR splenocytes were
transferred to unirradiated, syngeneic littermates (2  106 cells per bazole, respectively.
Immunity
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Immune Complex Deposition Scharff, M.D. (1992). The role of somatic mutation in the pathogenic
anti-DNA response. Annu. Rev. Immunol. 10, 731–757.SCID mice injected with 3  106 transfectoma cells were sacrificed
approximately 2 weeks later. Kidneys were flash frozen, and 6 M Dirkes, G., Kohler, G., and Kottmann, A.H. (1994). Sequence and
sections were prepared as above. Immune complex deposition was structure of the mouse IgH DQ52 5 region. Immunogenetics 40,
revealed with a FITC-labeled goat anti-mouse mAb (Southern Bio- 379–390.
technology Associates Inc., Birmingham, AL).
Erikson, J., Radic, M.Z., Camper, S.A., Hardy, R.R., Carmack, C.,
and Weigert, M. (1991). Expression of anti-DNA immunoglobulin
ANA Staining transgenes in non-autoimmune mice. Nature 349, 331–334.
ANA reactivity of purified mAbs was determined using human epi-
Fowler, E., and Cheng, N. (1983). Comparison of radioimmunoassaythelioid Hep-2 cells on prepared slides (Antibodies Incorporated,
and ELISA methods for detection of antibodies to chromatin compo-Davis, CA) according to the manufacturer’s instructions. Slides were
nents. J. Immunol. Methods 62, 297–303.stained with 20 l of 10 or 25 g/ml purified mAb. Bound antibodies
Gay, D., Saunders, T., Camper, S., and Weigert, M. (1993). Receptorwere detected with a FITC-labeled goat anti-mouse  antibody
editing: an approach by autoreactive B cells to escape tolerance.(Southern Biotechnology Associates, Birmingham, AL).
J. Exp. Med. 177, 999–1008.
Construction of the VHR55 Expression Vector Gillies, S.D., Morrison, S.L., Oi, V.T., and Tonegawa, S. (1983). A
and Electroporation of 36-65L Cells tissue specific transcription enhancer element is located in the major
A restriction fragment containing the R55VH region was isolated from intron of a rearranged immunoglobulin heavy chain gene. Cell 33,
an intermediate vector and ligated into the #223
2b expression 717–730.
vector (Gillies et al., 1983). A control #223
2b expression vector Giusti, A.M., Coffee, R., and Manser, T. (1992). Somatic recombina-
with the 36-65 VH (36-65/223) was also constructed using the same tion of heavy chain variable region transgenes with the endogenous
approach. Plasmids were then electroporated into the 36-65L cell immunoglobulin heavy chain locus in mice. Proc. Natl. Acad. Sci.
line (Sharon et al., 1984) as described (Sharon et al., 1989) with minor USA 89, 10321–10325.
modifications. Following 24–48 hr, transfectants were selected using
Goodnow, C.C. (1992). Transgenic mice and analysis of B-cell toler-mycophenolic acid for 7–10 days, and expression of secreted anti-
ance. Annu. Rev. Immunol. 10, 489–514.body was determined by an Ars ELISA (Casson and Manser, 1995;
Goodnow, C.C., Crosbie, J., Adelstein, S., Lavoie, T.B., Smith-Gill,Hande et al., 1998). Positive clones were expanded, and their mAbs
S.J., Brink, R.A., Pritchard-Briscoe, H., Wotherspoon, J.S., Loblay,were purified as described above.
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